{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:12:57Z","timestamp":1762125177077},"reference-count":30,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.3892\/ijo.2013.1960","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T10:11:24Z","timestamp":1369390284000},"page":"495-502","source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3"],"prefix":"10.3892","volume":"43","author":[{"given":"FANLIANG","family":"MENG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUIQIN","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEI","family":"ZHONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANHONG","family":"YU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOLLY A.","family":"BREWER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"key20180107183212_b1-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107183212_b2-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107183212_b3-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcp.21240","article-title":"Epithelialmesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm","volume":"13","author":"Ahmed","year":"2007","journal-title":"J Cell Physiol"},{"key":"key20180107183212_b4-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","article-title":"Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer","volume":"27","author":"Roy","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107183212_b5-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ygyno.2006.09.004","article-title":"Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer","volume":"104","author":"Sillanp\u00e4\u00e4","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180107183212_b6-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J Clin Invest"},{"key":"key20180107183212_b7-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4161\/cc.8.5.7703","article-title":"MMP-2 functions as an early response protein in ovarian cancer metastasis","volume":"8","author":"Kenny","year":"2009","journal-title":"Cell Cycle"},{"key":"key20180107183212_b8-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","article-title":"Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers","volume":"93","author":"Burleson","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key20180107183212_b9-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10585-004-5768-5","article-title":"Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers","volume":"21","author":"Burleson","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"key20180107183212_b10-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov"},{"key":"key20180107183212_b11-ijo-43-02-0495","first-page":"971","article-title":"Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo","volume":"7","author":"Vigushin","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107183212_b12-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2009.10.011","article-title":"Epigenetics and cancer treatment","volume":"625","author":"Kristensen","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"key20180107183212_b13-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1002\/cncr.26073","article-title":"Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2\/M arrest and autophagy","volume":"117","author":"Chen","year":"2011","journal-title":"Cancer"},{"key":"key20180107183212_b14-ijo-43-02-0495","article-title":"Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis","volume":"200177 e1","author":"Li","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107183212_b15-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-6-183","article-title":"Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients","volume":"6","author":"Sonnemann","year":"2006","journal-title":"BMC Cancer"},{"key":"key20180107183212_b16-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2009.09.039","article-title":"Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel induced apoptosis in ovarian cancer cell lines","volume":"116","author":"Dietrich","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107183212_b17-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107183212_b18-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells","volume":"28","author":"Baba","year":"2009","journal-title":"Oncogene"},{"key":"key20180107183212_b19-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","article-title":"Multicellular spheroids in ovarian cancer metastases: biology and pathology","volume":"113","author":"Shield","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20180107183212_b20-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1038\/onc.2010.234","article-title":"Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition","volume":"29","author":"Lin","year":"2010","journal-title":"Oncogene"},{"key":"key20180107183212_b21-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/MCB.24.1.306-319.2004","article-title":"Snail mediates E-cadherin repression by the recruitment of the Sin3A\/histone deacetylase 1 (HDAC1)\/HDAC2 complex","volume":"24","author":"Peinado","year":"2004","journal-title":"Mol Cell Biol"},{"key":"key20180107183212_b22-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"key":"key20180107183212_b23-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2007.11.151","article-title":"Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer","volume":"367","author":"Vesuna","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107183212_b24-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1210\/en.2006-0288","article-title":"Epigenetic regulation of human trophoblastic cell migration and invasion","volume":"147","author":"Rahnama","year":"2006","journal-title":"Endocrinology"},{"key":"key20180107183212_b25-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"key20180107183212_b26-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fgene.2011.00067","article-title":"Epigenomics of ovarian cancer and its chemoprevention","volume":"2","author":"Chen","year":"2011","journal-title":"Front Genet"},{"key":"key20180107183212_b27-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ajog.2004.05.025","article-title":"The epigenetics of ovarian cancer drug resistance and resensitization","volume":"191","author":"Balch","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107183212_b28-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/en.2009-0404","article-title":"Minireview: epigenetic changes in ovarian cancer","volume":"150","author":"Balch","year":"2009","journal-title":"Endocrinology"},{"key":"key20180107183212_b29-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107183212_b30-ijo-43-02-0495","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature04020","article-title":"LSD1 demethylates repressive histone marks to promote androgen-receptor dependent transcription","volume":"437","author":"Metzger","year":"2005","journal-title":"Nature"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1960\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:35:44Z","timestamp":1515350144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,5,24]]},"published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.3892\/ijo.2013.1960"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1960","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]}}}